lde225-600mg
Showing 1 - 1 of 1
Pancreatic Ductal Adenocarcinoma Trial in Baltimore (LDE225-600mg, Gemcitabine, nab-paclitaxel)
Terminated
- Pancreatic Ductal Adenocarcinoma
- LDE225-600mg
- +4 more
-
Baltimore, MarylandSidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Jan 17, 2020